252 related articles for article (PubMed ID: 26788497)
1. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.
Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G
Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497
[TBL] [Abstract][Full Text] [Related]
2. Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors.
Mega T; Lupia M; Amodio N; Horton SJ; Mesuraca M; Pelaggi D; Agosti V; Grieco M; Chiarella E; Spina R; Moore MA; Schuringa JJ; Bond HM; Morrone G
Cell Cycle; 2011 Jul; 10(13):2129-39. PubMed ID: 21593590
[TBL] [Abstract][Full Text] [Related]
3. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.
Harder L; Eschenburg G; Zech A; Kriebitzsch N; Otto B; Streichert T; Behlich AS; Dierck K; Klingler B; Hansen A; Stanulla M; Zimmermann M; Kremmer E; Stocking C; Horstmann MA
J Exp Med; 2013 Oct; 210(11):2289-304. PubMed ID: 24081948
[TBL] [Abstract][Full Text] [Related]
4. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.
Iglesias P; Puller AC; Seoane M; Spohn M; Raasch S; Klokow M; Müller J; Burkhardt L; Indenbirken D; Horstmann MA
Blood Adv; 2021 Mar; 5(5):1209-1223. PubMed ID: 33646306
[TBL] [Abstract][Full Text] [Related]
6. Defining B Cell Chromatin: Lessons from EBF1.
Boller S; Li R; Grosschedl R
Trends Genet; 2018 Apr; 34(4):257-269. PubMed ID: 29336845
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of Gata3 is essential for early B cell commitment.
Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D
Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.
Wang E; Kawaoka S; Roe JS; Shi J; Hohmann AF; Xu Y; Bhagwat AS; Suzuki Y; Kinney JB; Vakoc CR
Elife; 2015 Apr; 4():e06377. PubMed ID: 25919951
[TBL] [Abstract][Full Text] [Related]
9. The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function.
Boller S; Grosschedl R
Immunol Rev; 2014 Sep; 261(1):102-15. PubMed ID: 25123279
[TBL] [Abstract][Full Text] [Related]
10. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.
Zandi S; Mansson R; Tsapogas P; Zetterblad J; Bryder D; Sigvardsson M
J Immunol; 2008 Sep; 181(5):3364-72. PubMed ID: 18714008
[TBL] [Abstract][Full Text] [Related]
11. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
12. Comprehensive Proteomic Investigation of Ebf1 Heterozygosity in Pro-B Lymphocytes Utilizing Data Independent Acquisition.
Musa YR; Boller S; Puchalska M; Grosschedl R; Mittler G
J Proteome Res; 2018 Jan; 17(1):76-85. PubMed ID: 29181981
[TBL] [Abstract][Full Text] [Related]
13. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.
Lukin K; Fields S; Guerrettaz L; Straign D; Rodriguez V; Zandi S; Månsson R; Cambier JC; Sigvardsson M; Hagman J
Eur J Immunol; 2011 Jun; 41(6):1787-93. PubMed ID: 21469119
[TBL] [Abstract][Full Text] [Related]
14. Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming.
Boller S; Ramamoorthy S; Akbas D; Nechanitzky R; Burger L; Murr R; Schübeler D; Grosschedl R
Immunity; 2016 Mar; 44(3):527-541. PubMed ID: 26982363
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells.
Nechanitzky R; Akbas D; Scherer S; Györy I; Hoyler T; Ramamoorthy S; Diefenbach A; Grosschedl R
Nat Immunol; 2013 Aug; 14(8):867-75. PubMed ID: 23812095
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
Heckl D; Schwarzer A; Haemmerle R; Steinemann D; Rudolph C; Skawran B; Knoess S; Krause J; Li Z; Schlegelberger B; Baum C; Modlich U
Mol Ther; 2012 Jun; 20(6):1187-95. PubMed ID: 22472950
[TBL] [Abstract][Full Text] [Related]
17. B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1.
Hagman J; Ramírez J; Lukin K
Curr Top Microbiol Immunol; 2012; 356():17-38. PubMed ID: 21735360
[TBL] [Abstract][Full Text] [Related]
18. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
[TBL] [Abstract][Full Text] [Related]
20. Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis.
Li J; Bhattacharya S; Zhou J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
J Immunol; 2017 Nov; 199(10):3504-3515. PubMed ID: 28978690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
